It has a leading genetic portfolio enabling it to gain market share
Thursday 10 Sep 2020 Author: Martin Gamble
Genus ( GNS ) £37.40 Gain to Date: 31.4% Original entry point: Buy at £28.46, 19 September 2019 Despite the challenges of Covid-19 that affected supply chains in January and tough second-half comparisons, leading animal genetics company Genus ( GNS ) handsomely beat analyst forecasts again when it reported full-year results on 8 September, proving how resilient the business has become in recent years. Revenues grew 13% to 515.4...